molecular function |
| GO:0019958 | | C-X-C chemokine binding | | Interacting selectively and non-covalently with a C-X-C chemokine; C-X-C chemokines have a single amino acid between the first two cysteines of the characteristic four cysteine motif. |
| GO:0003677 | | DNA binding | | Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid). |
| GO:0008301 | | DNA binding, bending | | The activity of binding selectively and non-covalently to and distorting the original structure of DNA, typically a straight helix, into a bend, or increasing the bend if the original structure was intrinsically bent due to its sequence. |
| GO:0070182 | | DNA polymerase binding | | Interacting selectively and non-covalently with a DNA polymerase. |
| GO:0050786 | | RAGE receptor binding | | Interacting selectively and non-covalently with the RAGE receptor, the receptor for advanced glycation end-products. |
| GO:0000405 | | bubble DNA binding | | Interacting selectively and non-covalently with DNA that contains a bubble. A bubble occurs when DNA contains a region of unpaired, single-stranded DNA flanked on both sides by regions of paired, double-stranded DNA. |
| GO:0010858 | | calcium-dependent protein kinase regulator activity | | Modulates the activity of a calcium-dependent protein kinase, an enzyme which phosphorylates a protein in a calcium-dependent manner. |
| GO:0042056 | | chemoattractant activity | | Providing the environmental signal that initiates the directed movement of a motile cell or organism towards a higher concentration of that signal. |
| GO:0005125 | | cytokine activity | | Functions to control the survival, growth, differentiation and effector function of tissues and cells. |
| GO:0003684 | | damaged DNA binding | | Interacting selectively and non-covalently with damaged DNA. |
| GO:0003690 | | double-stranded DNA binding | | Interacting selectively and non-covalently with double-stranded DNA. |
| GO:0003725 | | double-stranded RNA binding | | Interacting selectively and non-covalently with double-stranded RNA. |
| GO:0000400 | | four-way junction DNA binding | | Interacting selectively and non-covalently with DNA containing four-way junctions, also known as Holliday junctions, a structure where two DNA double strands are held together by reciprocal exchange of two of the four strands, one strand each from the two original helices. |
| GO:0001530 | | lipopolysaccharide binding | | Interacting selectively and non-covalently with lipopolysaccharide. |
| GO:0016829 | | lyase activity | | Catalysis of the cleavage of C-C, C-O, C-N and other bonds by other means than by hydrolysis or oxidation, or conversely adding a group to a double bond. They differ from other enzymes in that two substrates are involved in one reaction direction, but only one in the other direction. When acting on the single substrate, a molecule is eliminated and this generates either a new double bond or a new ring. |
| GO:0001786 | | phosphatidylserine binding | | Interacting selectively and non-covalently with phosphatidylserine, a class of glycophospholipids in which a phosphatidyl group is esterified to the hydroxyl group of L-serine. |
| GO:0005515 | | protein binding | | Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules). |
| GO:0030295 | | protein kinase activator activity | | Binds to and increases the activity of a protein kinase, an enzyme which phosphorylates a protein. |
| GO:0070491 | | repressing transcription factor binding | | Interacting selectively and non-covalently with a transcription repressor, any protein whose activity is required to prevent or downregulate transcription. |
| GO:0003697 | | single-stranded DNA binding | | Interacting selectively and non-covalently with single-stranded DNA. |
| GO:0003727 | | single-stranded RNA binding | | Interacting selectively and non-covalently with single-stranded RNA. |
| GO:0097100 | | supercoiled DNA binding | | Interacting selectively and non-covalently with supercoiled DNA. For example, during replication and transcription, template DNA is negatively supercoiled in the receding downstream DNA and positively supercoiled in the approaching downstream DNA. |
| GO:0003700 | | transcription factor activity, sequence-specific DNA binding | | Interacting selectively and non-covalently with a specific DNA sequence in order to modulate transcription. The transcription factor may or may not also interact selectively with a protein or macromolecular complex. |
| GO:0008134 | | transcription factor binding | | Interacting selectively and non-covalently with a transcription factor, any protein required to initiate or regulate transcription. |
biological process |
| GO:0032392 | | DNA geometric change | | The process in which a transformation is induced in the geometry of a DNA double helix, resulting in a change in twist, writhe, or both, but with no change in linking number. Includes the unwinding of double-stranded DNA by helicases. |
| GO:0051103 | | DNA ligation involved in DNA repair | | The re-formation of a broken phosphodiester bond in the DNA backbone, carried out by DNA ligase, that contributes to DNA repair. |
| GO:0006310 | | DNA recombination | | Any process in which a new genotype is formed by reassortment of genes resulting in gene combinations different from those that were present in the parents. In eukaryotes genetic recombination can occur by chromosome assortment, intrachromosomal recombination, or nonreciprocal interchromosomal recombination. Intrachromosomal recombination occurs by crossing over. In bacteria it may occur by genetic transformation, conjugation, transduction, or F-duction. |
| GO:0006281 | | DNA repair | | The process of restoring DNA after damage. Genomes are subject to damage by chemical and physical agents in the environment (e.g. UV and ionizing radiations, chemical mutagens, fungal and bacterial toxins, etc.) and by free radicals or alkylating agents endogenously generated in metabolism. DNA is also damaged because of errors during its replication. A variety of different DNA repair pathways have been reported that include direct reversal, base excision repair, nucleotide excision repair, photoreactivation, bypass, double-strand break repair pathway, and mismatch repair pathway. |
| GO:0006265 | | DNA topological change | | The process in which a transformation is induced in the topological structure of a double-stranded DNA helix, resulting in a change in linking number. |
| GO:0035711 | | T-helper 1 cell activation | | The change in morphology and behavior of a T-helper 1 cell resulting from exposure to a mitogen, cytokine, chemokine, cellular ligand, or an antigen for which it is specific. |
| GO:0045063 | | T-helper 1 cell differentiation | | The process in which a relatively unspecialized T cell acquires the specialized features of a T-helper 1 (Th1) cell. A Th1 cell is a CD4-positive, alpha-beta T cell that has the phenotype T-bet-positive and produces interferon-gamma. |
| GO:0033151 | | V(D)J recombination | | The process in which immune receptor V, D, and J, or V and J gene segments, depending on the specific receptor, are recombined within a single locus utilizing the conserved heptamer and nonomer recombination signal sequences (RSS). |
| GO:0002218 | | activation of innate immune response | | Any process that initiates an innate immune response. Innate immune responses are defense responses mediated by germline encoded components that directly recognize components of potential pathogens. Examples of this process include activation of the hypersensitive response of Arabidopsis thaliana and activation of any NOD or TLR signaling pathway in vertebrate species. |
| GO:0032147 | | activation of protein kinase activity | | Any process that initiates the activity of an inactive protein kinase. |
| GO:0002250 | | adaptive immune response | | An immune response mediated by cells expressing specific receptors for antigen produced through a somatic diversification process, and allowing for an enhanced secondary response to subsequent exposures to the same antigen (immunological memory). |
| GO:0006309 | | apoptotic DNA fragmentation | | The cleavage of DNA during apoptosis, which usually occurs in two stages: cleavage into fragments of about 50 kbp followed by cleavage between nucleosomes to yield 200 bp fragments. |
| GO:0043277 | | apoptotic cell clearance | | The recognition and removal of an apoptotic cell by a neighboring cell or by a phagocyte. |
| GO:0006914 | | autophagy | | The process in which cells digest parts of their own cytoplasm; allows for both recycling of macromolecular constituents under conditions of cellular stress and remodeling the intracellular structure for cell differentiation. |
| GO:0006284 | | base-excision repair | | In base excision repair, an altered base is removed by a DNA glycosylase enzyme, followed by excision of the resulting sugar phosphate. The small gap left in the DNA helix is filled in by the sequential action of DNA polymerase and DNA ligase. |
| GO:0006974 | | cellular response to DNA damage stimulus | | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating damage to its DNA from environmental insults or errors during metabolism. |
| GO:0006935 | | chemotaxis | | The directed movement of a motile cell or organism, or the directed growth of a cell guided by a specific chemical concentration gradient. Movement may be towards a higher concentration (positive chemotaxis) or towards a lower concentration (negative chemotaxis). |
| GO:0031497 | | chromatin assembly | | The assembly of DNA, histone proteins, other associated proteins, and sometimes RNA, into chromatin structure, beginning with the formation of the basic unit, the nucleosome, followed by organization of the nucleosomes into higher order structures, ultimately giving rise to a complex organization of specific domains within the nucleus. |
| GO:0002407 | | dendritic cell chemotaxis | | The movement of a dendritic cell in response to an external stimulus. |
| GO:0035767 | | endothelial cell chemotaxis | | The directed movement of an endothelial cell guided by a specific chemical concentration gradient. Movement may be towards a higher concentration (positive chemotaxis) or towards a lower concentration (negative chemotaxis). |
| GO:0001935 | | endothelial cell proliferation | | The multiplication or reproduction of endothelial cells, resulting in the expansion of a cell population. Endothelial cells are thin flattened cells which line the inside surfaces of body cavities, blood vessels, and lymph vessels, making up the endothelium. |
| GO:0001654 | | eye development | | The process whose specific outcome is the progression of the eye over time, from its formation to the mature structure. The eye is the organ of sight. |
| GO:0002376 | | immune system process | | Any process involved in the development or functioning of the immune system, an organismal system for calibrated responses to potential internal or invasive threats. |
| GO:0006954 | | inflammatory response | | The immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. The process is characterized by local vasodilation, extravasation of plasma into intercellular spaces and accumulation of white blood cells and macrophages. |
| GO:0002437 | | inflammatory response to antigenic stimulus | | An inflammatory response to an antigenic stimulus, which can be include any number of T cell or B cell epitopes. |
| GO:0045087 | | innate immune response | | Innate immune responses are defense responses mediated by germline encoded components that directly recognize components of potential pathogens. |
| GO:0030324 | | lung development | | The process whose specific outcome is the progression of the lung over time, from its formation to the mature structure. In all air-breathing vertebrates the lungs are developed from the ventral wall of the oesophagus as a pouch which divides into two sacs. In amphibians and many reptiles the lungs retain very nearly this primitive sac-like character, but in the higher forms the connection with the esophagus becomes elongated into the windpipe and the inner walls of the sacs become more and more divided, until, in the mammals, the air spaces become minutely divided into tubes ending in small air cells, in the walls of which the blood circulates in a fine network of capillaries. In mammals the lungs are more or less divided into lobes, and each lung occupies a separate cavity in the thorax. |
| GO:0002281 | | macrophage activation involved in immune response | | A change in morphology and behavior of a macrophage resulting from exposure to a cytokine, chemokine, cellular ligand, or soluble factor, leading to the initiation or perpetuation of an immune response. |
| GO:0001773 | | myeloid dendritic cell activation | | The change in morphology and behavior of a dendritic cell resulting from exposure to a cytokine, chemokine, cellular ligand, or soluble factor. |
| GO:0043371 | | negative regulation of CD4-positive, alpha-beta T cell differentiation | | Any process that stops, prevents, or reduces the frequency, rate, or extent of CD4-positive, alpha-beta T cell differentiation. |
| GO:0017055 | | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly | | Any process that stops, prevents, or reduces the frequency, rate or extent of RNA polymerase II transcriptional preinitiation complex assembly. |
| GO:2000426 | | negative regulation of apoptotic cell clearance | | Any process that stops, prevents or reduces the frequency, rate or extent of apoptotic cell clearance. |
| GO:0043537 | | negative regulation of blood vessel endothelial cell migration | | Any process that stops, prevents, or reduces the frequency, rate or extent of the migration of the endothelial cells of blood vessels. |
| GO:0032689 | | negative regulation of interferon-gamma production | | Any process that stops, prevents, or reduces the frequency, rate, or extent of interferon-gamma production. Interferon-gamma is also known as type II interferon. |
| GO:0000122 | | negative regulation of transcription from RNA polymerase II promoter | | Any process that stops, prevents, or reduces the frequency, rate or extent of transcription from an RNA polymerase II promoter. |
| GO:0031175 | | neuron projection development | | The process whose specific outcome is the progression of a neuron projection over time, from its formation to the mature structure. A neuron projection is any process extending from a neural cell, such as axons or dendrites (collectively called neurites). |
| GO:0097350 | | neutrophil clearance | | The selective elimination of senescent neutrophils from the body by autoregulatory mechanisms. |
| GO:0002270 | | plasmacytoid dendritic cell activation | | A change in the morphology or behavior of a plasmacytoid dendritic cell resulting from exposure to an activating factor such as a cellular or soluble ligand. |
| GO:0050918 | | positive chemotaxis | | The directed movement of a motile cell or organism towards a higher concentration of a chemical. |
| GO:0043388 | | positive regulation of DNA binding | | Any process that increases the frequency, rate or extent of DNA binding. DNA binding is any process in which a gene product interacts selectively with DNA (deoxyribonucleic acid). |
| GO:0051106 | | positive regulation of DNA ligation | | Any process that activates or increases the frequency, rate or extent of DNA ligation, the re-formation of a broken phosphodiester bond in the DNA backbone, carried out by DNA ligase. |
| GO:0070374 | | positive regulation of ERK1 and ERK2 cascade | | Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade. |
| GO:0046330 | | positive regulation of JNK cascade | | Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the JNK cascade. |
| GO:0043410 | | positive regulation of MAPK cascade | | Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the MAPK cascade. |
| GO:1901224 | | positive regulation of NIK/NF-kappaB signaling | | Any process that activates or increases the frequency, rate or extent of NIK/NF-kappaB signaling. |
| GO:0042104 | | positive regulation of activated T cell proliferation | | Any process that activates or increases the rate or extent of activated T cell proliferation. |
| GO:0043065 | | positive regulation of apoptotic process | | Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process. |
| GO:0043280 | | positive regulation of cysteine-type endopeptidase activity involved in apoptotic process | | Any process that activates or increases the activity of a cysteine-type endopeptidase involved in the apoptotic process. |
| GO:0007204 | | positive regulation of cytosolic calcium ion concentration | | Any process that increases the concentration of calcium ions in the cytosol. |
| GO:2001200 | | positive regulation of dendritic cell differentiation | | Any process that activates or increases the frequency, rate or extent of dendritic cell differentiation. |
| GO:0045819 | | positive regulation of glycogen catabolic process | | Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of glycogen. |
| GO:0045089 | | positive regulation of innate immune response | | Any process that activates or increases the frequency, rate or extent of the innate immune response, the organism's first line of defense against infection. |
| GO:0032727 | | positive regulation of interferon-alpha production | | Any process that activates or increases the frequency, rate, or extent of interferon-alpha production. |
| GO:0032728 | | positive regulation of interferon-beta production | | Any process that activates or increases the frequency, rate, or extent of interferon-beta production. |
| GO:0050718 | | positive regulation of interleukin-1 beta secretion | | Any process that activates or increases the frequency, rate or extent of the regulated release of interleukin-1 beta from a cell. |
| GO:0050716 | | positive regulation of interleukin-1 secretion | | Any process that activates or increases the frequency, rate or extent of the regulated release of interleukin-1 from a cell. |
| GO:0032733 | | positive regulation of interleukin-10 production | | Any process that activates or increases the frequency, rate, or extent of interleukin-10 production. |
| GO:0032735 | | positive regulation of interleukin-12 production | | Any process that activates or increases the frequency, rate, or extent of interleukin-12 production. |
| GO:0032755 | | positive regulation of interleukin-6 production | | Any process that activates or increases the frequency, rate, or extent of interleukin-6 production. |
| GO:2000778 | | positive regulation of interleukin-6 secretion | | Any process that activates or increases the frequency, rate or extent of interleukin-6 secretion. |
| GO:0032425 | | positive regulation of mismatch repair | | Any process that activates or increases the frequency, rate or extent of mismatch repair. |
| GO:0090026 | | positive regulation of monocyte chemotaxis | | Any process that increases the frequency, rate, or extent of monocyte chemotaxis. |
| GO:0045639 | | positive regulation of myeloid cell differentiation | | Any process that activates or increases the frequency, rate or extent of myeloid cell differentiation. |
| GO:0001934 | | positive regulation of protein phosphorylation | | Any process that activates or increases the frequency, rate or extent of addition of phosphate groups to amino acids within a protein. |
| GO:1903672 | | positive regulation of sprouting angiogenesis | | Any process that activates or increases the frequency, rate or extent of sprouting angiogenesis. |
| GO:0034137 | | positive regulation of toll-like receptor 2 signaling pathway | | Any process that activates or increases the frequency, rate, or extent of toll-like receptor 2 signaling pathway. |
| GO:0034145 | | positive regulation of toll-like receptor 4 signaling pathway | | Any process that activates or increases the frequency, rate, or extent of toll-like receptor 4 signaling pathway. |
| GO:0034165 | | positive regulation of toll-like receptor 9 signaling pathway | | Any process that activates or increases the frequency, rate, or extent of toll-like receptor 9 signaling pathway. |
| GO:0045944 | | positive regulation of transcription from RNA polymerase II promoter | | Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter. |
| GO:0032760 | | positive regulation of tumor necrosis factor production | | Any process that activates or increases the frequency, rate, or extent of tumor necrosis factor production. |
| GO:0090303 | | positive regulation of wound healing | | Any process that increases the rate, frequency, or extent of the series of events that restore integrity to a damaged tissue, following an injury. |
| GO:0002840 | | regulation of T cell mediated immune response to tumor cell | | Any process that modulates the frequency, rate, or extent of a T cell mediated immune response to tumor cell. |
| GO:0010506 | | regulation of autophagy | | Any process that modulates the frequency, rate or extent of autophagy. Autophagy is the process in which cells digest parts of their own cytoplasm. |
| GO:2000819 | | regulation of nucleotide-excision repair | | Any process that modulates the frequency, rate or extent of nucleotide-excision repair. |
| GO:0045859 | | regulation of protein kinase activity | | Any process that modulates the frequency, rate or extent of protein kinase activity. |
| GO:0032072 | | regulation of restriction endodeoxyribonuclease activity | | Any process that modulates the frequency, rate or extent of a restriction endodeoxyribonuclease activity, the catalysis of endonucleolytic cleavage of DNA in a site-specific manner, resulting in double-strand breaks. |
| GO:0002643 | | regulation of tolerance induction | | Any process that modulates the frequency, rate, or extent of tolerance induction. |
| GO:0006357 | | regulation of transcription from RNA polymerase II promoter | | Any process that modulates the frequency, rate or extent of transcription from an RNA polymerase II promoter. |
| GO:0051384 | | response to glucocorticoid | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glucocorticoid stimulus. Glucocorticoids are hormonal C21 corticosteroids synthesized from cholesterol with the ability to bind with the cortisol receptor and trigger similar effects. Glucocorticoids act primarily on carbohydrate and protein metabolism, and have anti-inflammatory effects. |
| GO:1990774 | | tumor necrosis factor secretion | | The regulated release of tumor necrosis factor from a cell. Tumor necrosis factor is an inflammatory cytokine produced by macrophages/monocytes during acute inflammation and which is responsible for a diverse range of signaling events within cells, leading to necrosis or apoptosis. |
cellular component |
| GO:0009986 | | cell surface | | The external part of the cell wall and/or plasma membrane. |
| GO:0005694 | | chromosome | | A structure composed of a very long molecule of DNA and associated proteins (e.g. histones) that carries hereditary information. |
| GO:0000793 | | condensed chromosome | | A highly compacted molecule of DNA and associated proteins resulting in a cytologically distinct structure. |
| GO:0005737 | | cytoplasm | | All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
| GO:0005769 | | early endosome | | A membrane-bounded organelle that receives incoming material from primary endocytic vesicles that have been generated by clathrin-dependent and clathrin-independent endocytosis; vesicles fuse with the early endosome to deliver cargo for sorting into recycling or degradation pathways. |
| GO:0005793 | | endoplasmic reticulum-Golgi intermediate compartment | | A complex system of membrane-bounded compartments located between endoplasmic reticulum (ER) and the Golgi complex, with a distinctive membrane protein composition; involved in ER-to-Golgi and Golgi-to-ER transport. |
| GO:0005768 | | endosome | | A vacuole to which materials ingested by endocytosis are delivered. |
| GO:0005576 | | extracellular region | | The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite. |
| GO:0005615 | | extracellular space | | That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid. |
| GO:0016020 | | membrane | | A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it. |
| GO:0043005 | | neuron projection | | A prolongation or process extending from a nerve cell, e.g. an axon or dendrite. |
| GO:0005654 | | nucleoplasm | | That part of the nuclear content other than the chromosomes or the nucleolus. |
| GO:0005634 | | nucleus | | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. |
| GO:0005886 | | plasma membrane | | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
| GO:0017053 | | transcriptional repressor complex | | A protein complex that possesses activity that prevents or downregulates transcription. |